In pre-clinical and clinical research models, ARA-290 has demonstrated significant activity across multiple domains: Neuropathy and Pain Research: Diabetic peripheral neuropathy (DPN) Phase 2 clinical study confirmed ARA-290 significantly improved HbA1c, lipid profiles, and neuropathic symptom scores in type 2 diabetes patients over 56 days
Besouw MTP, Van Dyck M, Francois I, Van Hoyweghen E, Levtchenko EN (2012) Detailed studies of growth hormone secretion in cystinosis patients
According to an older 2013 review of research, they may have lipotropic effects in rodents: Very limited research exists on the efficacy, safety, and lipotropic properties of the ingredients used in these injections for weight loss
Such research has the potential to pave the way for more personalized and effective treatments
It's a new generation sunscreen agent that was specifically designed for high SPF and good UVA protection and based on a 2007 study that compared 18 sunscreen agents available in the EU it really had the best SPF protection (they used the highest concentration allowed by EU regulations from each 18 sunscreens and Trinosorb S gave an SPF 20 all by itself)